LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Oregon Upstart Offers $90 Screw
Spine

Oregon Upstart Offers $90 Screw

August 27, 2014 1 min read Premium comments

Advertisement

Oregon Upstart Offers $90 Screw
Courtesy: Impact Medical
Secondary

The headless 3 millimeter compression screw placed in a hip or knee costs $385 from one leading manufacturer. An upstart, based in Portland, Oregon, is selling that same screw for $90—a 76% reduction. Elizabeth Hayes, staff reporter for the Portland Business Journal, tells the story of Impact Medical and its founder and CEO, E.J. Duffy, who says that his orthopedic implants are made out of the exact same stainless steel as are those from other manufacturers.

“We were able to reverse engineer a lot of products, ” Duffy told Hayes. “We get our competitors’ products, give them to our engineer and we find a manufacturer to build it to our specs. The point is, you can’t tell the difference between them.”

The market in which Duffy and his company, Impact Medical, participate has annual sales of more than 1.7 billion dollars. Impact Medical presently has customers in seven states.

The U.S. Food and Drug Administration has given Impact Medical clearance for numerous products: including 11 types of screws, two styles of plates for bone fixation and assorted K-wires and drill bits. Duffy says that more screws, plates, cables and an external fixator device are in the pipeline. Clearance by the FDA certifies that the company’s products are similar or better than products currently on the market.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy